Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.46 |
| ▸ | MAPK8 | P45983 | 2/20 | 0.45 |
| ▸ | PGR | P06401 | 4/20 | 0.45 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28038182 | 0.86 | KMT2A (0.41) | KDM4EATML3MBTL1MAPK1KMT2A | |
| SCHEMBL11849396 | 0.86 | METAP2 (0.46) | KDM4EATML3MBTL1MAPK1KMT2A | |
| SCHEMBL10834564 | 0.82 | MAPT (0.60) | KDM4EL3MBTL1KMT2AALDH1A1HPGD | |
| SCHEMBL26128587 | 0.80 | MAT2A (0.55) | L3MBTL1KMT2AMEN1MAPK8MAPK9 | |
| SCHEMBL30611290 | 0.80 | MAT2A (0.51) | ATMMAPK1MAPK8MAPK9PMM2 | |
| SCHEMBL29110301 | 0.80 | MAT2A (0.51) | ATMMAPK1MAPK8MAPK9PMM2 | |
| SCHEMBL30611304 | 0.80 | MAT2A (0.55) | L3MBTL1KMT2AMEN1MAPK8MAPK9 | |
| SCHEMBL5130586 | 0.80 | ELANE (0.43) | KDM4EL3MBTL1MAPK1KMT2AALDH1A1 | |
| SCHEMBL11016646 | 0.79 | PLA2G10 (0.47) | ALDH1A1CYP1A2PMM2LMNAMPI | |
| SCHEMBL10982087 | 0.78 | MAOB (0.55) | L3MBTL1KMT2AMEN1CA9BCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110511188-B | Preparation method of 2-imino dihydro quinazolinone compound | 烟台大学 | 2022-09-20 | — | — | CN | claimed |
| US-12365762-B2 | Dispersant for coating system | BASF SE (DE) | 2025-07-22 | — | — | US | disclosed |
| US-12024595-B2 | Polymer composition | BASF SE (DE) | 2024-07-02 | — | — | US | disclosed |
| CN-112867751-B | Dispersants for coating systems | 巴斯夫欧洲公司 | 2023-10-27 | — | — | CN | disclosed |
| EP-3215558-B1 | NOVEL POLYMER COMPOSITIONS AND USE OF THESE POLYMER COMPOSITIONS AS DISPERSANTS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| EP-3837301-B1 | POLYMER COMPOSITION | BASF SE (DE) | 2022-06-15 | — | — | EP | disclosed |
| US-20210347950-A1 | POLYMER COMPOSITION | BASF SE (DE) | 2021-11-11 | — | — | US | disclosed |
| US-20210230362-A1 | A DISPERSANT FOR COATING SYSTEM | BASF SE (DE) | 2021-07-29 | — | — | US | disclosed |
| CN-112912420-A | Polymer composition | 巴斯夫欧洲公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-112867751-A | Dispersants for coating systems | 巴斯夫欧洲公司 | 2021-05-28 | — | — | CN | disclosed |
| US-20160102198-A1 | NOVEL POLYMER DISPERSANTS | BASF SE (DE) | 2016-04-14 | — | — | US | disclosed |
| US-20150038640-A1 | NOVEL POLYMER DISPERSANTS | BASF SE (DE) | 2015-02-05 | — | — | US | disclosed |
| US-20080139551-A1 | TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES | AVANIR PHARMACEUTICALS (US) | 2008-06-12 | — | — | US | disclosed |
| WO-2007038571-A2 | PROLYL HYDROXYLASE ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-04-05 | — | — | WO | disclosed |
| US-5190956-A | Certain N-substituted 3-oximino-2,4-dioxoquinolin-2,4-(1H)diones useful for treating viral infections | SCHERING CORPORATION (US) | 1993-03-02 | — | — | US | disclosed |
| US-5179107-A | Herpes | SCHERING CORPORATION (US) | 1993-01-12 | — | — | US | disclosed |
| US-4604464-A | Immunomodulatory 3-(substituted aminobenzoyl)-3,4-dihydrophthalazin-1(2H)-ones | PENNWALT CORPORATION (US) | 1986-08-05 | — | — | US | disclosed |
| US-4058532-A | 1-Phenyl-3,4-dihydrocarbostyrils | STERLING DRUG INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-4049715-A | 3-[2-(4-Anisidino)phenyl]-1-phenyl-1-propiophenones and propanols | STERLING DRUG INC. (US) | 1977-09-20 | — | — | US | disclosed |
| US-3994902-A | Certain 1,2-diphenyl-1,2,3,4-tetrahydroquinoline compounds | STERLING DRUG INC. (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080139551-A1 | TUMOR NECROSIS FACTOR ALPHA INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN DISEASES | TNF, TNFRSF1A, TNFRSF9 | KDM4E 4691/4885ATM 4475/4885L3MBTL1 3091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.